XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Preferred Stock
Class C Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Other Comprehensive Loss
Total
Balance, Beginning at Dec. 31, 2021 $ 10,275 $ 50 $ 1,100,287 $ (467,541) $ (1,243) $ 641,828
Balance, Beginning (in shares) at Dec. 31, 2021 200,000 49,616,154        
Net loss       (27,897)   (27,897)
Other comprehensive income (loss), net of taxes         (41,685) (41,685)
Stock-based compensation expense     14,749     14,749
Paid-in-kind preferred stock dividend $ 6,000   (6,000)      
Issuance of common stock for Cell&Co acquisition (in shares)   15,152        
Issuance of common stock for Cell&Co acquisition     479     479
Repurchase of common stock (in shares)   (1,341,571)        
Repurchase of common stock   $ (1) (24,999) (8,349)   (33,349)
Vesting of restricted stock units (in shares)   97,062        
Proceeds from exercise of stock options (in shares)   171,634        
Proceeds from exercise of stock options     1,596     1,596
Balance, Ending at Sep. 30, 2022 $ 16,275 $ 49 1,086,112 (503,787) (42,928) 555,721
Balance, Ending (in shares) at Sep. 30, 2022 200,000 48,558,431        
Balance, Beginning at Dec. 31, 2021 $ 10,275 $ 50 1,100,287 (467,541) (1,243) $ 641,828
Balance, Beginning (in shares) at Dec. 31, 2021 200,000 49,616,154        
Repurchase of common stock (in shares)           (1,604,994)
Balance, Ending at Dec. 31, 2022 $ 18,275 $ 48 1,114,896 (542,832) (34,549) $ 555,838
Balance, Ending (in shares) at Dec. 31, 2022 200,000 48,334,280        
Balance, Beginning at Jun. 30, 2022 $ 14,275 $ 49 1,081,747 (498,471) (29,176) 568,424
Balance, Beginning (in shares) at Jun. 30, 2022 200,000 48,482,502        
Net loss       (5,316)   (5,316)
Other comprehensive income (loss), net of taxes         (13,752) (13,752)
Stock-based compensation expense     5,366     5,366
Paid-in-kind preferred stock dividend $ 2,000   (2,000)      
Vesting of restricted stock units (in shares)   4,500        
Proceeds from exercise of stock options (in shares)   71,429        
Proceeds from exercise of stock options     999     999
Balance, Ending at Sep. 30, 2022 $ 16,275 $ 49 1,086,112 (503,787) (42,928) 555,721
Balance, Ending (in shares) at Sep. 30, 2022 200,000 48,558,431        
Balance, Beginning at Dec. 31, 2022 $ 18,275 $ 48 1,114,896 (542,832) (34,549) 555,838
Balance, Beginning (in shares) at Dec. 31, 2022 200,000 48,334,280        
Net loss       (37,198)   (37,198)
Other comprehensive income (loss), net of taxes         448 448
Stock-based compensation expense     16,960     $ 16,960
Paid-in-kind preferred stock dividend $ 6,000   (6,000)      
Repurchase of common stock (in shares)           0
Vesting of restricted stock units (in shares)   221,623        
Proceeds from exercise of stock options (in shares)   407,814       407,814
Proceeds from exercise of stock options   $ 1 1,479     $ 1,480
Balance, Ending at Sep. 30, 2023 $ 24,275 $ 49 1,127,335 (580,030) (34,101) 537,528
Balance, Ending (in shares) at Sep. 30, 2023 200,000 48,963,717        
Balance, Beginning at Jun. 30, 2023 $ 22,275 $ 49 1,123,180 (566,761) (34,488) 544,255
Balance, Beginning (in shares) at Jun. 30, 2023 200,000 48,879,018        
Net loss       (13,269)   (13,269)
Other comprehensive income (loss), net of taxes         387 387
Stock-based compensation expense     5,976     5,976
Paid-in-kind preferred stock dividend $ 2,000   (2,000)      
Vesting of restricted stock units (in shares)   12,499        
Proceeds from exercise of stock options (in shares)   72,200        
Proceeds from exercise of stock options     179     179
Balance, Ending at Sep. 30, 2023 $ 24,275 $ 49 $ 1,127,335 $ (580,030) $ (34,101) $ 537,528
Balance, Ending (in shares) at Sep. 30, 2023 200,000 48,963,717